#4-07E. From Ancient Poison to Modern Panacea: The Evolution of Colchicine (LancetRheumatol, 2026)

Are you aware of the millennia-long history behind colchicine, a daily staple in the management of acute gout flares? This historical review delineates the fascinating trajectory of colchicum, tracing its transformation from a feared toxic botanical in antiquity to its establishment as a cornerstone pharmacotherapy in modern rheumatology. The most pivotal clinical takeaway is the contemporary expansion of colchicine's therapeutic indications—extending beyond autoinflammatory conditions to secure FDA approval for cardiovascular disease prevention. While this highlights the enduring relevance of the drug, readers must critically note that this article is a historical narrative review rather than primary original research, meaning it does not independently validate new clinical efficacy or safety profiles. For practicing physicians, understanding this two-thousand-year therapeutic continuity underscores the importance of revisiting established empirical medications, offering a profound reminder that modern therapeutic innovation can often be discovered by re-evaluating ancient clinical traditions.

Citation: Pascart T, Drouin E. Colchicum and gout: two millennia of therapeutic continuity. The Lancet Rheumatology. 2026. DOI: 10.1016/S2665-9913(26)00073-1

Disclaimer: This audio summary is based on personal interpretation and does not guarantee the exact content of the original paper. Please refer to the original article for details.